Articles publiés en 2019

Posters réalisés en 2018
10 avril 2018

Belhassen, M, Tubach, F, Hudry, C, et al
Impact of Persistence with Tumor Necrosis Factor Inhibitors on Healthcare Resource Utilization and Costs in Chronic Inflammatory Joint Diseases
Br J Clin Pharmacol. 2020
Doi:10.1111/bcp.14387
PMID: 32441383
Vervloet M, van Dijk L, Spreeuwenberg P, et al.
The Relationship Between Real-World Inhaled Corticosteroid Adherence and Asthma Outcomes: A Multilevel Approach.
J Allergy Clin Immunol Pract. 2020;8(2):626–634.
Doi:10.1016/j.jaip.2019.09.003
PMID: 31541763
Dalon F, Devouassoux G, Belhassen M, Nachbaur G, Correia Da Silva C, Sail L, Jacoud F, Chouaid C, Van Ganse E.
Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy.
Int J Chron Obstruct Pulmon Dis. 2019:14 2905–2915
Doi:10.2147/COPD.S222762
PMID: 31908439
Belhassen M, Nolin M, Nibber A, Ginoux M, Devouassoux G, Van Ganse E.
Changes in Persistent Asthma Care and Outcomes From 2006 to 2016 in France.
J Allergy Clin Immunol Pract. 2019 Jul – Aug;7(6):1858-1867.
Doi: 10.1016/j.jaip.2019.02.025.
PMID: 30836232
Article: Link
Paul Guedeney, Victor Aboyans, Faustine Dalon, Dina Oksen, Manon Belhassen, Maeva Nolin, Jean-Baptiste Briere, Eric Van Ganse, Gilles Montalescot.
Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in France.
Épidémiologie, traitements et pronostic des patients avec maladie coronaire ou artériopathie des membres inférieurs, en France Arch Cardiovasc Dis. 2019 Nov 7. pii: S1875-2136(19)30174-3.
doi: 10.1016/j.acvd.2019.05.009.
PMID: 31708441
Dalon F, Roche N, Belhassen M, Nolin M, Pegliasco H, Deslée G, Housset B, Devillier P, Van Ganse E.
Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study
Int J Chron Obstruct Pulmon Dis. 2019 Aug 20;14:1839-1854.
doi: 10.2147/COPD.S214061
PMID: 31692478
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D’Urzo AD, Roche N.
Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
Ann Am Thorac Soc. 2019 Sep;16(9):1143-1150.
doi: 10.1513/AnnalsATS.201809-607OC
PMID: 31162945
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D’Urzo AD, Roche N.
Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
Ann Am Thorac Soc. 2019 Sep;16(9):1143-1150.
doi: 10.1513/AnnalsATS.201809-607OC
PMID: 31162945
Dalon F, Van Ganse E, Correia Da Silva C, Nachbaur G, Saïl L, Belhassen M.
Therapeutic adherence in chronic obstructive pulmonary disease: A literature review
Rev Mal Respir. 2019 Jul 9.
doi: 10.1016/j.rmr.2019.06.005
PMID: 31300244
Picard F, Van Ganse E, Ducrocq G, Danchin N, Falissard B, Hanon O, Belhassen
M, Ginoux M, Lefevre C, Cotte FE, Mahé I, Steg PG.
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study.
Clin Cardiol. 2019 Jul 17.
doi: 10.1002/clc.23231
PMID: 31313832
Alfred Mahr, Manon Belhassen, Marc Paccalin, Valérie Devauchelle-Pensec, Maeva Nolin, Sophie Gandon, Isabelle Idier, Eric Hachulla
Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data.
Rheumatology, 2019 June 25.
doi: 10.1093/rheumatology/kez251
Téléchargement: ici.
Manon Belhassen, Van Ganse E
Pharmacoépidémiologie dans l’asthme.
La lettre du Pneumologue. 2019 Mai-Juin.
Article: Voir
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, Van Boven
JF, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, Van
Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK,
Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, Roche N.
Prevalence and Characteristics of Asthma-COPD Overlap in Routine Primary Care Practices.
Ann Am Thorac Soc. 2019 Jun 4.
doi: 10.1513/AnnalsATS.201809-607OC
PMID: 31162945
Campbell JD, Perry R, Papadopoulos NG, Krishnan J, Brusselle G, Chisholm A,
Bjermer L, Thomas M, Van Ganse E, Van den Berge M, Quint J, Price D, Roche N.
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies.
Clin Transl Allergy. 2019 Mar 27;9:21.
doi: 10.1186/s13601-019-0256-9
PMID: 30962876
Roche N, Campbell JD, Krishnan JA, Brusselle G, Chisholm A, Bjermer L, Thomas M, Van Ganse E, Van den Berge M, Christoff G, Quint J, Papadopoulos NG, Price D.
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.
Clin Transl Allergy. 2019 Mar 27;9:20.
doi: 10.1186/s13601-019-0255-x
PMID: 30962875
Manon Belhassen, Maëva Nolin, Anjan Nibber, Marine Ginoux, Gilles Devouassoux, Eric Van Ganse.
Changes in persistent asthma care and outcomes from 2006 to 2016 in France.
J Allergy Clin Immunol Pract. 2019 Mar 2. pii: S2213-2198(19)30202-8.
doi: 10.1016/j.jaip.2019.02.025.
PMID: 30836232
Hernandez G, Garin O, Dima AL, Pont A, Martí Pastor M, Alonso J, Van Ganse E, Laforest L, de Bruin M, Mayoral K, Serra-Sutton V, Ferrer M; ASTRO-LAB Group. EuroQol (EQ-5D-5L)
Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
J Med Internet Res. 2019 Jan 23;21(1):e10178.
doi: 10.2196/10178
PMID: 30672744